The transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units, as ...
Jay S. Stout, the Chief Technology Officer at Immunovant, Inc. (NASDAQ:IMVT), has sold 2,195 shares of the company's common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback